Possible association of anti-tumor necrosis factor-&#945; antibody therapy with the development of scleroderma-like changes with lichen planus.

Inoue-Nishimoto, Tomoko; Hanafusa, Takaaki; Igawa, Ken; Azukizawa, Hiroaki; Yokomi, Akinori; Yokozeki, Hiroo; Katayama, Ichiro

Possible association of anti-tumor necrosis factor-α antibody therapy with the development of scleroderma-like changes with lichen planus.

Inoue-Nishimoto, Tomoko; Hanafusa, Takaaki; Igawa, Ken; Azukizawa, Hiroaki; Yokomi, Akinori; Yokozeki, Hiroo; Katayama, Ichiro.

Afiliação

Inoue-Nishimoto T; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
Hanafusa T; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan., Department of Dermatology, Tokyo Medical and Dental University, Graduate School of Medicine, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan.
Igawa K; Department of Dermatology, Tokyo Medical and Dental University, Graduate School of Medicine, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan.
Azukizawa H; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
Yokomi A; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
Yokozeki H; Department of Dermatology, Tokyo Medical and Dental University, Graduate School of Medicine, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan.
Katayama I; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.

Eur J Dermatol ; 25(5): 513-5, 2015.

Article em En | MEDLINE | ID: mdl-26242643

Assuntos

Adalimumab/efeitos adversos; Líquen Plano/induzido quimicamente; Psoríase/tratamento farmacológico; Esclerodermia Localizada/induzido quimicamente; Fator de Necrose Tumoral alfa/antagonistas & inibidores; Adalimumab/uso terapêutico; Adulto; Biópsia por Agulha; Toxidermias/etiologia; Toxidermias/patologia; Quimioterapia Combinada; Feminino; Seguimentos; Humanos; Imuno-Histoquímica; Líquen Plano/tratamento farmacológico; Líquen Plano/patologia; Psoríase/diagnóstico; Medição de Risco; Esclerodermia Localizada/tratamento farmacológico; Esclerodermia Localizada/patologia; Índice de Gravidade de Doença; Resultado do Tratamento; Fator de Necrose Tumoral alfa/administração & dosagem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Esclerodermia Localizada / Fator de Necrose Tumoral alfa / Adalimumab / Líquen Plano Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google